Treatment with Tyrosine Kinase Inhibitors for Patients with Differentiated Thyroid Cancer: the M. D. Anderson Experience
Year: 2010
Type: article
Study design: Observational Study
DOI: 10.1210/jc.2009-1923
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: differentiated thyroid cancer, tyrosine kinase inhibitors, sorafenib, sunitinib, radioiodine-refractory thyroid cancer, off-label drug use, progression-free survival, radiological response, thyroglobulin, papillary thyroid carcinoma, follicular thyroid carcinoma, metastatic thyroid cancer, lung metastasis, lymph node metastasis, bone metastasis, pleural disease, overall survival
Open Access status: closed
OpenAlex ID: W2102084843
